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Background: Intensive cognitive-behavioral therapy (CBT) can effectively reduce symp-
toms in obsessive–compulsive disorder (OCD). However, many relapse after treatment.
Few studies have investigated biological markers predictive of follow-up clinical status.
The objective was to determine if brain network connectivity patterns prior to intensive
CBT predict worsening of clinical symptoms during follow-up.
Methods: We acquired resting-state functional magnetic resonance imaging data from
17 adults with OCD prior to and following 4weeks of intensive CBT. Functional connec-
tivity data were analyzed to yield graph-theory metrics. We examined the relationship
between pre-treatment connectome properties and OCD clinical symptoms before and
after treatment and during a 12-month follow-up period.
Results: Mean OCD symptom decrease was 40.416.4% pre- to post-treatment
(64.7% responded; 58.8% remitted), but 35.3% experienced clinically significant wors-
ening during follow-up. From pre- to post-treatment, small-worldness and clustering
coefficient significantly increased. Decreases in modularity correlated with decreases in
OCD symptoms. Higher pre-treatment small-world connectivity was significantly associ-
ated with worsening of OCD symptoms during the follow-up period. Psychometric and
neurocognitive measures pre- and post-treatment were not significant predictors.
Conclusion: This is the first graph-theory connectivity study of the effects of CBT in OCD,
and the first to test associations with follow-up clinical status. Results show functional
network efficiency as a biomarker of CBT response and relapse in OCD. CBT increases
network efficiency as it alleviates symptoms in most patients, but those entering therapy
with already high network efficiency are at greater risk of relapse. Results have potential
clinical implications for treatment selection.
Keywords: brain network, connectome, resting-state fMRI, graph theory, CBT
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Introduction
Obsessive–compulsive disorder (OCD) is characterized by recur-
rent, intrusive, disturbing thoughts (obsessions), and/or stereo-
typed recurrent behaviors (compulsions) (1). Lifetime prevalence
is 1–2%. Untreated OCD results in marked distress, and impaired
functioning in social, occupational, and educational domains (2).
Cognitive-behavioral therapy (CBT) is an effective treatment
for OCD (3). CBT typically consists of weekly outpatient treat-
ment or intensive daily treatment over several weeks. Intensive
CBT is particularly effective, resulting in sustained benefits (4, 5).
Notwithstanding, post-treatment relapse has been observed in
roughly 20% of patients receiving CBT for OCD (6–12). Across
studies, rates of relapse range widely from 0 to 50% (13). This vari-
ability may relate to differences in treatment parameters, patient
characteristics, and even the definition of relapse (14). Although
CBT is associated with significant symptom improvement and
with lower relapse than a time-limited course of pharmacotherapy
(13–19), many clinical questions remain. One important question
is: what factors help predict whowill remain in remission andwho
will relapse after treatment?
While there is some evidence for predictors of short-term
response to treatment (20–22), fewer studies have addressed the
equally important question of sustained response, or, conversely,
worsening after treatment (23, 24). Several naturalistic follow-
up studies have attempted to identify predictors of symptom
course. One study followed a cohort for 21months after a 12-
week randomized trial of groupCBTor fluoxetine (25). Comorbid
affective disorders, any comorbid psychiatric condition, and ill-
ness duration were associated with higher post-treatment OCD
symptoms. A study that followed an OCD cohort treated with
12 sessions of group CBT for 2 years found that full remission of
symptoms at the end of treatment protected against relapse (26).
Another study followed patients for 6 years after receiving CBT
with clomipramine or placebo. Greater amount of CBT, better
homework compliance, and improvement at the end of treatment
were associated with better outcomes (9). Likewise, in a meta-
analysis of pediatric OCD, severity of illness, comorbid diagnoses,
and poor initial treatment response were associated with worse
longitudinal course (27). However, another study that followed
patients 6–8 years after CBT plus fluvoxamine or placebo did not
find an association between short-term treatment response and
long-term outcome (28).
Prognostic factors that could serve as biomarkers of relapse
after treatment would have potential use in clinical decision-
making. For example, factors such as psychometric scores or
neurocognitive profiles; or measurements of brain activity, con-
nectivity, morphometry, or neurochemical profiles associated
with relapse could be identified prior to a particular treatment
and could be used to determine whether an alternative treatment
should be pursued.
Measurement of brain activity is a logical target for identifi-
cation of putative biomarkers of clinical outcome, since multiple
studies associate OCDwith hyperactivity in frontostriatal systems
(29, 30). Resting-state functional magnetic resonance imaging
(rsfMRI) is increasingly used to understand functional brain con-
nectivity in psychiatric disorders. Analyses of rsfMRI data allow
for examination of spontaneous fluctuations in the blood–oxygen
level-dependent (BOLD) signal, revealing underlying intrinsic
connectivity networks. rsfMRI studies in OCD have detected
aberrant connectivity in frontostriatal and parietal regions that
may contribute to the emergence and severity of OCD symptoms
(31, 32).
Graph theory is an analysis technique used to study rsfMRI
that provides information about the topology of intrinsic brain
connectivity networks (33). Graph theory provides quantitative
analyses of complex brain networks as a whole, rather than being
limited to discrete pairs of regions. To date, there have been
only two graph-theory studies of OCD. One found abnormally
low connectivity in posterior temporal cortex, and abnormally
high connectivity in middle cingulate, precuneus, thalamus, and
cerebellum (34). A second study found abnormally low cluster-
ing coefficient, small-worldness, and local efficiency in OCD at
baseline (35). Further, medication treatment was associated with
increased small-worldness, clustering coefficient, local efficiency,
and modularity.
The goal of the current study was to investigate, for the first
time, if pre-treatment functional network connectivity measures
predict worsening of OCD symptoms subsequent to CBT treat-
ment. An additional goal was to determine the effects of intensive
CBT on global brain network connectivity using graph theory.We
emphasized pre-treatment rather than post-treatment values in
order to uncover potential biomarkers that could provide useful
input to early clinical decision-making about selection of treat-
ment modality. We determined graph-theory metrics of rsfMRI
network connectivity in individuals with OCD prior to and fol-
lowing 4weeks of intensive CBT.We then followed individuals for
up to 12months post treatment, and determined the relationship
betweenpre-treatment connectivitymetrics and follow-up clinical
symptomatology.
We hypothesized that intensive CBT would result in increases
in functional network efficiency – mean clustering coefficient,
local efficiency, and small-worldness – and modularity, based
on the previous study of OCD treatment (35). In addition, we
predicted a significant relationship between these graph-theory
metrics pre-treatment and worsening of core OCD symptoms
at follow-up. Moreover, we hypothesized that these connectiv-
ity measures, being less subjective and effort-dependent, would
demonstrate stronger associations with follow-up clinical status
than psychometric and neurocognitive variables.
Materials and Methods
Participants
Seventeen right-handed adults ages 21–50 diagnosed with
DSM-IVOCD (36) participated. Participants were recruited from
UCLA clinics, local psychiatrists and psychotherapists, flyers, and
Internet advertisements. All provided written informed consent,
and the UCLA Institutional Review Board approved the study.
Diagnoses of OCD participants were established through detailed
interviews conducted by one of the authors (JDF), who has clin-
ical experience with this population. Primary OCD and comor-
bid diagnoses were determined using the ADIS-IV-Mini (37).
Participants were eligible if they scored 16 on the Yale–Brown
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TABLE 1 | Demographics of OCD participants.
Demographics
Total participants (N) 17
Gender (F/M) 9/8
Age (years) 34.09.43
Years of education 16.062.19
IQ (WASI) 109.416.14
No comorbidities/comorbidities 2/15
Medicated/unmedicated during intensive CBT phase 3/14
Medication treatment only during follow-up phase N= 4
CBT only during follow-up phase N= 8
Medications and CBT during follow-up phase N= 2
No treatment during follow-up phase N= 3
Mean follow-up duration (mo.) 74.53
WASI, Wechsler Abbreviated Scales of Intelligence; CBT, cognitive-behavioral therapy.
Obsessive–Compulsive Scale (YBOCS) (38). Exclusion criteria
included a psychotic disorder, bipolar disorder, lifetime substance
dependence, or attention-deficit hyperactivity disorder. Comor-
bid anxiety disorders were allowed, as long as OCD was the
primary diagnosis. Comorbid major depressive disorder (MDD)
or dysthymic disorder was allowed, but individuals were excluded
if theADIS-IV clinical significance ratingwas 6 or higher (severe).
Unmedicated or medicated participants were included, but sero-
tonin reuptake inhibitors were the only class of medication
allowed. In addition, they could not have had any changes (dose
or agent) to their medication within 12weeks prior to enrollment.
Other exclusion criteria included IQ<80 on theWechsler Abbre-
viated Scales of Intelligence (WASI) (39) and medical conditions
that affect cerebral metabolism (e.g., thyroid disorders, diabetes).
We also excluded those with prior courses of CBT for OCD
consisting of 30 sessions, in order to minimize the possibility
that such patients may already have experienced putative brain
changes induced by CBT. Demographics and psychometrics are
reported in Tables 1 and 2, and Table S1 in Supplementary
Material. Three individuals were taking stable doses of serotonin
reuptake inhibitors (two fluoxetine, one escitalopram) and 14
were unmedicated.
Psychometric Evaluations
An independent evaluator, not involved in treatment or initial
assessments, administered the psychometric instruments post-
treatment and during the follow-up period. After 4weeks of inten-
sive CBT, participants returned to care as usual, which may have
included medication treatment and/or psychotherapy (CBT or
other), or no treatment. Thus, the follow-up period was naturalis-
tic rather than controlled.
The primary outcome was the YBOCS (38). The YBOCS is
a reliable and valid semi-structured clinical interview assessing
OCD severity and change over time. It has excellent psychome-
tric properties and sensitivity to treatment. Treatment response
was defined as a 35% reduction of YBOCS total score and a
Clinical Global Improvement (CGI) score of 2; remission was
defined as a YBOCS score of 14 (40). Secondary outcome mea-
sures pre- to post-treatment included the Hamilton Anxiety Scale
(HAMA) (41) and the Montgomery-Åsberg Depression Rating
Scale (MADRS) (42). A general rating of functionality and of
social and occupational performance was provided by the Global
Assessment Scale (GAS) (43).
We also administered the StroopColor–Word Interference Task
(44) to measure response inhibition. Within this neurocognitive
task, the interference trial requires the participant to inhibit a
pre-potent response in order to provide a correct answer. We
used interference scores as a secondary independent variable of
interest.
Clinical Procedures
All participants underwent intensive CBTwith an individual ther-
apist, consisting of 90-min sessions, 5 days per week, for 4weeks.
(For additional details see Supplementary Material.)
Following treatment, participants underwent the Stroop task
and psychometric evaluations. They were then followed over a
period of 1–12months (mean 7 4.53). Follow-up assessments
included the YBOCS, MADRS, HAMA, the Sheehan Disability
Scale (45), and the Quality of Life Enjoyment and Satisfaction
Questionnaire Short Form (Q-LES-Q) (46).
fMRI Acquisition
Participants were scanned prior to and following 4weeks of CBT.
Magnetic resonance datawere acquired at 3 Tusing a SiemensTrio
with 12-channel headcoil.Whole-brain fMRIwas collected using a
7-minecho-planar imaging (EPI) sequence (TR/TE= 2000/25ms,
flip angle= 78°, voxels 3mm3, 35 interleaved slices with 1-mm
gap). Participants were instructed to rest with eyes closed, to
remain as still as possible, and not to sleep. High-resolution T1-
weighted whole-brain structural MRI was acquired using an axial
MPRAGE sequence (TR/TE= 1900/3.26ms, voxels 1mm3), used
for registration of BOLD data.
rsfMRI Processing
Functional data were preprocessed using FMRI Software Library
(FSL) version 5.0.41. To allow for magnetization equilibrium, we
discarded the first two images. Data were slice-time corrected,
were motion-corrected (MCFLIRT), and band-pass filtered
(0.009–0.08Hz). A seven degrees-of-freedom (DOF) transform
was used to register each participant’s functional image to the
MPRAGE, and a 12-DOF transform was used to register the
MPRAGE to Montreal Neurological Institute (MNI) standard
atlas space. All images were inspected for proper registration to
the MNI template. Data were then resampled to 2-mm space.
White matter, CSF, and temporal derivatives were removed by
linear regression, as were six head motion parameters. Motion
was assessed using DVARS (root mean squared change in BOLD
signal from volume to volume), and one participant was excluded
whose DVARS exceeded 25% (47). There was no difference in
motion pre-and post-treatment, as indicated by DVARS mea-
sured for each subject across the time-series (9.69 1.51 pre-CBT
and 9.29 1.16 post-CBT; P= 0.33) (Figure S2 in Supplementary
Material).
Brain Network Extraction
Onehundred sixty functionally defined nodeswere used, covering
the whole brain, as previously described (48) (Figure 1). Nodes
1http://www.fmrib.ox.ac.uk/fsl
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TABLE 2 | Psychometrics of OCD participants.
Psychometric Pre-treatment Post-treatment Follow-up Statistic df P value
YBOCS 23:12 3:04a 13:76 4:25b 15:47 6:65c F= 26.62 1.44, 22.98 <0:001
HAMA 11:94 4:78e 8:06 4:66f 9:12 4:92g F= 5.85 2, 32 0:007
MADRS 12:12 5:51 9:53 9:71 10:00 4:86 F= 0.85 1.43, 22.89 0:40
GAS 59:06 6:65h 74:06 13:66i 73:65 10:95j F= 14.58 2, 32 <0:001
Stroop interference 54:59 7:37 54:47 7:88 N/A t= 0.10 16 0:92
Sheehan (%) N/A N/A 27:25 20:56 N/A N/A N/A
QLESQ (%) N/A N/A 59:56 10:13 N/A N/A N/A
YBOCS, Yale Brown Obsessive–Compulsive Scale; HAMA, Hamilton Anxiety Scale; MADRS, Montgomery Åsberg Depression Rating Scale; GAS, Global Assessment Scale; Sheehan,
Sheehan Disability Scale; QLESQ, Quality of Life Enjoyment and Satisfaction Questionnaire Short Form.
a vs. b: P<0.001; a vs. c: P=0.001; b vs. c: P=0.673; e vs. f: P=0.011; e vs. g: P=0.079; f vs. g: P=1; h vs. i: P<0.001; h vs. j: P< 0.001; i vs. j: P=1.
FIGURE 1 | Sagittal, axial, and coronal views of the 160 nodes used for the graph-theory analysis.
were 10mm in diameter and non-overlapping. Applying these
nodes to each individual’s rsfMRI time-series data, all pairwise
partial correlation coefficients between nodes were calculated.We
chose partial over full correlations as the former make topological
parameters less sensitive to motion, especially at higher density
thresholds (49). (We additionally performed Pearson full correla-
tion analyses – see SupplementaryMaterial.) Using the BrainCon-
nectivity toolbox http://www.brain-connectivity-toolbox.net/, we
derived weighted, undirected graphs, or functional connectivity
matrices, for each participant.
In graph theory, a network comprises “nodes” (here, func-
tionally defined ROIs from five meta-analyses of fMRI activation
studies) and the connections or “edges” between them (in this
case, partial correlation values). The clustering coefficient of a
node is the ratio of the number of actual connections among its
first-degree neighbors to the number of all possible such con-
nections. Thus, a high clustering coefficient for a node indicates
that its neighbors are strongly inter-connected. Mean clustering
coefficient is the average of the clustering coefficient for all nodes
in the network; high values may confer greater local efficiency
of information transfer in a network (33). Global efficiency is
mathematically defined by averaging the inverse shortest path
lengths across all node pairs. (Path length is theminimumnumber
of intermediate nodes needed to pass through in order to link
any node pair.) High global efficiency represents high overall
capacity for parallel information transfer and integrated process-
ing (50). Small-worldness is mean clustering coefficient divided
by characteristic path length. Modularity measures how strongly
nodes in a community interconnect in comparison to nodes in
a random graph. Thus, the higher the modularity of a given
community structure, the less likely it is the result of chance alone.
Modularity quantifies the degree to which the network may be
subdivided into such clearly delineated modules. In the brain,
balance between segregation of specialized systems (modules) and
integration across systems is essential for efficient information
processing and rapid information transfer within and between
networks (51, 52).
From the connectivity matrices, we calculated small-world
parameters (including mean clustering coefficient, small-
worldness, local and global efficiencies), and modularity, to
examine global network topologies. For small-world analysis, we
used the sparsity threshold S to define the small-world regime
(0.10 S 0.50). Each small-world attribute was compared with
those of 100 random networks to produce a normalized value,
and areas under the curve (AUC) were calculated for statistical
comparisons.
Statistical Analyses
We tested relationships between pre-treatment graph-theory net-
work measures and change in OCD symptoms during follow-up
using multiple linear regression in SPSS®. All data were checked
for normality of distributions and for outliers. We tested small-
worldness, mean clustering coefficient, global efficiency, local
efficiency, and modularity. The primary outcome was change in
YBOCS from post-treatment to the follow-up time point. For
the prediction of follow-up score analyses, we controlled for the
number of months post-treatment at which follow-up data were
acquired, as well as for number ofmonths ofmedication treatment
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and number of CBT sessions (if any) in the follow-up period,
and for motion (DVARS for the pre-CBT scan). Because small-
worldness is a function of clustering coefficient and (the inverse
of) global efficiency, and local efficiency and clustering coefficient
are related and therefore non-independent, we use a Bonferroni-
corrected α threshold of 0.05/3= 0.017 for the independent
statistical metrics (clustering coefficient, global efficiency, and
modularity).
Secondary analyses examined whether clinical (HAMA and
MADRS scores) or neurocognitive (Stroop interference scores)
variables pre- or post-treatment significantly predicted follow-up
YBOCS score changes. A Bonferroni-corrected α threshold of
0.05/6= 0.0083 was used for statistical significance.
To assess differences pre- to post-treatment within-group, we
compared AUC values obtained across the range of sparsities. We
applied multiple linear regression before computation to remove
the confounding effects ofmotion (DVARS) for each graph-theory
metric. We performed paired t-tests, or one-sample permuta-
tion tests in R2, for data that were normally or non-normally
distributed, respectively. A significance threshold of α= 0.017,
two-tailed, was applied, as above.
As exploratory analyses, we tested for pre- to post-CBT changes
at the level of individual regions for all 160 nodes, for the graph-
theorymetrics node degree, clustering coefficient, local efficiency,
betweenness centrality, and edge betweenness centrality. We used
false discovery rate (FDR) to correct for multiple comparisons for
eachmetric, with a q value set at.05/4= 0.0125 (to account for four
independent tests of metrics, as clustering coefficient and local
efficiency are related) as the significance threshold.
Results
Treatment Response and Follow-Up Clinical Data
Follow-up data were available for all 17 participants. Mean dura-
tion of follow-up was 7 4.53months. Four participants received
medication only in the follow-up period, eight were treated with
CBT only, two with medications and CBT, and three received no
treatment (Table 1).
All 17 participants completed treatment. Mean YBOCS
scores decreased 40.4 16.4% from pre- to post-treatment
[t(16)= 10.00,P< 0.0001] (Table 2). Eleven (64.7%)were respon-
ders and 10 (58.8%) achieved remission.
There was a mean increase in YBOCS from post-treatment to
follow-up of 13.98 50.91%. Six (35.3%) experienced clinically
significant worsening of symptoms during follow-up consisting of
5 points worsening on YBOCS (53).
Pre- to Post-Treatment Changes in Graph-Theory
Global Network Metrics
Small-worldness AUC significantly increased from pre- to
post-treatment (P= 0.012), as did mean clustering coefficient
(P= 0.0093) (Figures 2 and 3). There were non-significant
increases in local efficiency (P= 0.070), non-significant decreases
in modularity (P= 0.12), and non-significant decreases in global
efficiency (P= 0.18). Post hoc analyses excluding medicated
2http://www.r-project.org/
individuals resulted in similar significant findings, with the excep-
tion that modularity significantly decreased from pre- to post-
treatment (P= 0.012) (see Supplementary Material).
Changes in small-worldness were relatively consistent across
the sample, with 16 of 17 participants demonstrating increases
pre- to post-treatment (although 2 were minimally changed)
(Figure 4). Mean clustering coefficient increased in 15 of 17.
As post hoc analyses, we tested partial correlations between
changes in networkmetrics and changes in OCD symptom scores,
controlling for motion (mean pre- and post-CBT DVARS). We
used a Bonferroni-corrected α threshold of 0.05/3= 0.0167 for
statistical significance. Change in modularity was significantly
correlated with change in YBOCS from pre- to post-treatment
(r= 0.64; P= 0.007). That is, decreases in modularity were asso-
ciated with decreases in OCD symptoms. Correlations were non-
significant for changes in small-worldness (r= 0.42; P= 0.10),
mean clustering coefficient (r= 0.42; P= 0.10), global effi-
ciency (r= 0.13; P= 0.63), and local efficiency (r= 0.13;
P= 0.64).
Exploratory Node-Level Analyses of Pre- to
Post-Treatment Changes in Graph-Theory
Metrics
There were no significant differences for any nodes pre- to
post-CBT for node degree, clustering coefficient, local efficiency,
betweenness centrality, and edge betweenness centrality, after
FDR correction (see Table S2 in Supplementary Material).
Graph-Theory Metric Predictions of Follow-Up
OCD Symptom Scores
Pre-treatment small-worldness was significantly associated
with follow-up change in YBOCS scores (adjusted R2= 0.642;
F5,11= 6.75, P= 0.004) (Figure 5), as was pre-treatment
mean clustering coefficient (adjusted R2= 0.647; F5,11= 6.87,
P= 0.004). For both metrics, higher pre-treatment values
were associated with worsening on YBOCS. Global
efficiency (adjusted R2= 0.21; F5,11= 1.83, P= 0.19), local
efficiency (adjusted R2= 0.074; F5,11= 1.25, P= 0.35),
and modularity (adjusted R2= 0.032; F5,11= 0.90,
P= 0.51) were not significant predictors of follow-up score
changes.
Reanalysis of the data after excluding the three participants tak-
ingmedications during the pre- to post-treatment period revealed
that pre-treatment small-worldness continued to be significantly
associated with follow-up change in YBOCS (adjusted R2= 0.661;
F5,8= 6.08, P= 0.013), as was pre-treatment mean clustering
coefficient (adjusted R2= 0.664; F5,8= 6.15, P= 0.013). In addi-
tion, global efficiency was associated with follow-up change in
YBOCS (adjusted R2= 0.593; F5,8= 4.79, P= 0.025), although
not surviving correction for multiple comparisons; lower pre-
treatment global efficiency was associated with worsening on
YBOCS.
As post hoc exploratory analyses, we investigated the rela-
tionships between the graph-theory metrics and additional
clinical measures of anxiety (HAMA), depression (MADRS),
quality of life (Q-LES-Q), and general functioning (Sheehan)
at follow-up. We used a Bonferroni-corrected α threshold
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FIGURE 2 | Plot of graph-theory metrics pre- and post-treatment, derived from partial correlation matrices across sparsity levels from 0.1 to 0.5:
(A) small-worldness, (B) clustering coefficient, (C) global efficiency, (D) local efficiency, (E) modularity. Error bars are 1 SD.
of 0.05/12= 0.004 (four clinical variables three independent
graph-theory metrics). None of the global graph-theory metrics
were significantly associated with HAMA, MADRS, Q-LES-Q, or
Sheehan scores.
Clinical and Neurocognitive Predictors of
Follow-Up OCD Symptom Scores
Yale–Brown Obsessive–Compulsive Scale scores pre-treatment
(adjusted R2= 0.002, F4,12= 0.99, P= 0.49) or post-treatment
(adjusted R2= 0.009, F4,12= 1.04, P= 0.43) did not predict
follow-up YBOCS. HAMA scores pre-treatment (adjusted
R2= 0.15, F4,12= 1.73, P= 0.21) and post-treatment (adjusted
R2= 0.009, F4,12= 1.04, P= 0.43) did not predict follow-up
YBOCS scores, nor did MADRS scores pre-treatment (adjusted
R2= 0.002, F4,12= 1.01, P= 0.44) or post-treatment (adjusted
R2= 0.29, F4,12= 2.53, P= 0.10). Stroop interference scores
pre-treatment (adjusted R2= 0.001, F4,12= 0.99, P= 0.45) and
post-treatment (adjusted R2= 0.002, F4,12= 1.01, P= 0.44) did
not predict follow-up YBOCS. Number ofmonths onmedications
and number of follow-up CBT sessions either modeled separately
(adjusted R2= 0.10, F2,14= 0.26, P= 0.77 for medications;
adjusted R2= 0.070, F2,14= 1.60, P= 0.24 for CBT) or together
(adjusted R2= 0.075, F3,13= 1.43, P= 0.28) did not significantly
predict YBOCS scores.
Discussion
This is the first study to identify neuroimaging predictors of
longitudinal clinical course subsequent to treatment for OCD. It
is also the first to test effects of CBT treatment on brain network
connectivity using graph theory. Results suggest that small-world
network efficiency increases in almost all patients during CBT,
but that patients with higher pre-treatment efficiency are more
prone to relapse. Thus, increasing network efficiencymay beCBT-
associated pathways to recovery from OCD, but patients with
already high network efficiency may be at greater risk of relapse
of OCD symptoms.
Prediction of Longitudinal Clinical Status
As hypothesized, mean clustering coefficient and small-
worldness significantly predicted follow-up OCD symptom
severity, although, contrary to prediction, global efficiency and
modularity did not. Mean clustering coefficient and small-
worldness were better predictors than clinical measures including
OCD symptom severity and anxiety and depression before or after
treatment. Likewise, they performed better than a neurocognitive
measure of response inhibition (Stroop), which was not
significantly associated with follow-up scores. Surprisingly,
months of medication and number of CBT therapy sessions in
the follow-up period also did not predict OCD symptom severity.
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Thus, global measures of brain connectivity show the strongest
relationship with symptom course subsequent to intensive CBT
over any clinical or neurocognitive measure tested.
Changes in Network Connectivity with Treatment
As hypothesized, results demonstrated significant pre- to post-
treatment increases in individuals with OCD in small-worldness
and mean clustering coefficient, although increases in local effi-
ciency were not significant. Modularity, contrary to prediction,
did not significantly increase from pre- to post-treatment. These
observations of increases in small-worldness and mean cluster-
ing coefficient, but no increases in global efficiency, replicate
FIGURE 3 | Plots of average values for area-under-the-curve network
metrics with pre-treatment in black and post-treatment in red. Metrics
that are significantly different (P<0.0167) pre- vs. post-treatment are
indicated by an asterisk.
FIGURE 4 | Plots showing change in metrics for individual participants pre- vs. post-treatment. The data for each plot were sorted by the pre-treatment
values. Pre-treatment values are shown with black circles and post-treatment as red circles: (A) small-worldness, (B) clustering coefficient.
findings in a study of OCD treatment with medication (35),
althoughwe did not observe similar changes inmodularity. There-
fore, theremay be non-specific effects of treatment on small-world
efficiencymeasures, but divergent effects of CBT andmedications
on community network structure.
Interestingly, thosewith lower small-worldness and lowermean
clustering coefficient pre-treatment were less likely to experience
worsening of their OCD symptoms in the follow-up period. These
values increased significantly with treatment, although the great-
est increases were for those with low pre-treatment values. This
suggests that while CBT may improve network efficiency, this
effect is strongest in those who start with low brain network
efficiency. Moreover, these individuals do better longitudinally,
in terms of sustaining or even further decreasing OCD symptom
severity.
Small-world organization of brain connectivity provides for
efficiency in local information processing; high local neighbor-
hood clustering and long-distance connections offer a high degree
of efficient global communication across the network and integra-
tion from different sub-specialized neighborhoods (33, 54–56).
Since small-worldness is a function of high clustering coefficient
and low characteristic path length (inverse of global efficiency),
in the current study, the increases in small-world efficiency
subsequent to treatment are driven by increases inmean clustering
coefficient, while global efficiency remains relatively unaffected.
Clustering coefficient is a measure of functional segregation;
higher mean clustering coefficient means that, on average, each
region’s neighbors are more highly connected with each other.
This can also be thought of as more densely inter-connected local
networks of brain regions that confer segregated neural processing
(57), for example, perhaps those involved in specialized brain
functions such as attunement to specific auditory frequencies, or
consolidation of fear learning in local limbic circuits. Thus, in
our study, the finding of increased small-worldness as a result
of increased clustering coefficient means that the brain networks
have increased their overall efficiency through enhanced regional
processing efficiency conferred by more dense connections, while
retaining the same long distance connections (no significant
changes in global efficiency) that are important for integration of
information (57). Since increases in small-worldness and mean
clustering coefficient were not correlated with improvements in
OCD symptoms pre- to post-treatment, the mechanism of CBT
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FIGURE 5 | (A) Scatterplot of small-worldness values vs. observed YBOCS
changes in the post-treatment follow-up period; (B) linear regression results
of predicted YBOCS changes vs. observed YBOCS changes. Note: (A) is
shown purely to display the relationship between the two variables, while
(B) depicts the linear regression results that control for the covariates of
non-interest.
in effecting improvements in network efficiency could be inde-
pendent from direct effects on obsessive thoughts and compulsive
behaviors.
One possible mechanism could relate to general effects that
CBT may have in helping patients organize their thoughts, feel-
ings, and behaviors, and improve their ability to be a “rational
observer” of these phenomena in their mind. This may relate to
improvements through extended psychoeducation and practice
in monitoring their experience, which can deepen their under-
standing of the mental processes inherent to OCD. Improve-
ment in these areas, which provides the foundation and enhances
insight to further address obsessions and compulsions with the
behavioral (exposure and response prevention) stage of treatment,
might confer increases in brain network efficiency. This aspect of
CBTmight allow for disparate, functionally segregated processing
of emotions, thought patterns, sensory–motor experiences, and
planned/executed behaviors to become more integrated into con-
scious awareness, which subsequently may be reflected in changes
in small-world properties. Those with already high network effi-
ciency when treatment begins may represent a more refractory
group in the long-term, as they already may be employing these
techniques but have not improved or remained well; this is the
group that is at most risk for relapse. This conjectural interpre-
tation, however, needs to be further explored and confirmed in
future studies that could, for example, test effects of these com-
ponents of psychoeducation and early stages of CBT, in isolation
from its behavioral components.
Decreases in modularity with treatment were correlated with
improvements in OCD symptoms. Optimal modularity implies
an ideal number of communities in the network (58). Low
modularity suggests relative isolation of certain nodes. Thus,
CBT-associated decrease in modularity may reflect a declining
influence of certain “pernicious” nodes (e.g., symptom-driving
hyperactive frontostriatal loops) on network dynamics, which
are associated with improvements in OCD symptoms. Alterna-
tively, the observed reduction in modularity in response to CBT
associated with reduction in OCD symptoms may result from
remodeling of brain network modular structure (i.e., shifting
membership of nodes in the various modules). Another possible
explanation is that reductions in modularity values reflect the
development of cognitive compensatory mechanisms allowing
for greater control over obsessions and compulsions and hence
improved symptoms; indirect evidence for this comes from a
study that found that, within individuals, reductions in functional
modularity were associated with enhanced workingmemory (59).
Clinical Implications
In our sample, small-world network efficiencywas a biomarker for
longitudinal outcome in OCD subsequent to CBT. The effective-
ness of CBT is well documented and beyond doubt, as exemplified
in the current study that produced a high proportion of responders
and remitters. Hence, a more useful clinical question for the
application of biomarkers is not who will respond to treatment,
but rather who will remain well and/or continue to improve after
treatment. rsfMRI is a relatively easy to perform procedure that
could be administered and replicated across sites, lending this
method both to larger trials to confirm its utility in providing
network connectivity measures to assist with clinical decision-
making, and, if confirmed, ultimately in actual use in clinical set-
tings. Contrary to this, predictors that involve neuropsychological
factors may be less reliable than other, objective measurements
such as resting-state brain connectivity due to the fact that they are
highly effort-dependent and in some cases evaluator-dependent.
These findingsmay also set the stage for testing different treatment
durations to reduce risk of relapse. Adequate studies have not
been conducted to determine the duration of treatment optimal
for preventing relapse (60).
Limitations
One limitation of this study is the small sample size, which may
have constrained our ability to detect smaller changes in network
measures and/or relationships with follow-up clinical status. This
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may have also accounted for the lack of significant node-level
differences in graph-theory metrics pre- to post-treatment, for
which we likely had insufficient power given the need to correct
for multiple comparisons across 160 nodes. Another limitation,
inherent to studies of a specific treatment modality that may
restrict generalizability to the OCD population on the whole;
it is possible that the OCD participants in this study may have
“self-selected” for willingness to engage in difficult and intense
exposure and response, which in turn likely results in significant
reduction in symptoms.
Conclusion
Brain organization characterized by less dense local functional
connections (lower clustering coefficient and therefore lower
small-worldness) prior to CBT confers greater maintenance of
treatment gains. CBT increases network efficiency as it alleviates
symptoms in most patients, but patients entering CBT with
already high-network efficiency are at greater risk of relapse.
Results show functional network efficiency as a biomarker of CBT
response and relapse in OCD, which has potential implications
for clinical decision-making and treatment selection. These results
warrant further investigation and replication in a larger dataset.
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